Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

NETWORK × Disease × carfilzomib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Multiple Myeloma 7 Disease 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Ovarian Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 3 carfilzomib 2 Dexamethasone 2 deltacortene 1 daratumumab 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Calcium Dobesilate 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01857115 2024-11-13

wCCyd

European Myeloma Network B.V.

Phase 1/2 Completed

Disease, Multiple Myeloma

NCT02204241 2023-07-03

CCD

European Myeloma Network B.V.

Phase 1/2 Completed

Disease, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡